Lantheus Holdings (LNTH) reported $1.5B in revenue for fiscal 2025, +0.5% year on year. That ranks #1491 by revenue among 2853 SEC filers and #132 in Healthcare. Net income was $234M, a net margin of 15.2%. Revenue has grown 15.1% a year on average since 2013 ($284M then). The fiscal 2025 balance sheet shows $2.2B in total assets, $359M in cash and $569M in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.5B | +0.5% | FY20252025-12-31 |
| Gross profitGrossProfit | $942M | −4.7% | FY20252025-12-31 |
| Operating incomeOperatingIncomeLoss | $311M | −32.0% | FY20252025-12-31 |
| Net incomeNetIncomeLoss | $234M | −25.2% | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $390M | −28.4% | FY20252025-12-31 |
| Capital expenditurePaymentsForCapitalImprovements | $36.1M | −30.1% | FY20252025-12-31 |
| Total assetsAssets | $2.2B | +12.5% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $1.1B | +0.2% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $359M | −60.7% | FY20252025-12-31 |
| Long-term debtLongTermDebtAndCapitalLeaseObligations | $569M | +0.6% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $377M | $118M | Open → |
| Q2 20262026-06-30 | $388M | $75.0M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 37 of 161 companies compared | 15.2% | |
| Operating marginRank 34 of 160 companies compared | 20.2% | |
| R&D as share of revenueRank 41 of 102 companies compared | 11.5% | |
| Cash as share of revenueRank 40 of 160 companies compared | 23.3% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Lantheus Holdings, Inc.
- Ticker
- LNTH
- Exchange
- Nasdaq
- SIC classification
- In Vitro & In Vivo Diagnostic Substances (2835)
- Fiscal year end
- 12-31
- CIK
- 0001521036
Filings
- 10-QAug 6, 2026Open filing →
- 10-QMay 7, 2026Open filing →
- 10-KFeb 26, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| 111YI | $1.8B | −$3.2M |
| PTC TherapeuticsPTCT | $1.7B | $683M |
| Integra LifesciencesIART | $1.6B | −$517M |
| Lantheus HoldingsLNTH | $1.5B | $234M |
| National HealthcareNHC | $1.5B | $120M |
| Merit Medical SystemsMMSI | $1.5B | $128M |
| Nu Skin EnterprisesNUS | $1.5B | $160M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Lantheus Holdings — Key figures |url=https://companiesranked.com/en/company/lantheus-holdings |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Lantheus Holdings — Key figures. CompaniesRanked. https://companiesranked.com/en/company/lantheus-holdingsBibTeX
@misc{companiesranked-en-company-lantheus-holdings-2026,
author = {{CompaniesRanked}},
title = {{Lantheus Holdings — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/lantheus-holdings}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001193125-26-073498 · February 26, 2026
{{cite web |title=Lantheus Holdings — Key figures — 10-K (0001193125-26-073498) |url=https://www.sec.gov/Archives/edgar/data/1521036/000119312526073498/lnth-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.